Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Investor Update Call
February 03 2021 - 4:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it
will host its fourth quarter and full year 2020 investor update
conference call and webcast at 8:30 a.m. Eastern Time on Wednesday,
February 17, 2021. Individuals interested in participating in the
call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932
(international) using conference ID number and event passcode
4598414. To access the webcast, please visit the Investors section
of Ironwood’s website at www.ironwoodpharma.com at least 15 minutes
prior to the start of the call to ensure adequate time for any
software downloads that may be required.
The call will be available for replay via telephone starting
Wednesday, February 17, 2021 at approximately 11:30 a.m. Eastern
Time, running through 11:59 p.m. Eastern Time on March 3, 2021. To
listen to the replay, dial (800) 585-8367 (U.S. and Canada) or
(416) 621-4642 (international) using conference ID number 4598414.
The archived webcast will be available on Ironwood’s website for 14
days beginning approximately one hour after the call has
completed.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused
healthcare company dedicated to creating medicines that make a
difference for patients living with GI diseases. We discovered,
developed and are commercializing linaclotide, the U.S. branded
prescription market leader for adults with irritable bowel syndrome
with constipation (IBS-C) or chronic idiopathic constipation
(CIC).
Ironwood was founded in 1998 and is headquartered in Boston,
Mass. For more information, please visit our website at
www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210203005873/en/
Media and Investors: Meredith Kaya, 617-374-5082 Vice
President, Strategy, Investor Relations and Corporate
Communications mkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jul 2023 to Jul 2024